Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Debt (2017 - 2021)

Historic Total Debt for AC Immune (ACIU) over the last 4 years, with Q3 2020 value amounting to $336773.3.

  • AC Immune's Total Debt fell 4741.49% to $336773.3 in Q3 2020 from the same period last year, while for Sep 2020 it was $336773.3, marking a year-over-year decrease of 4741.49%. This contributed to the annual value of $656409.3 for FY2019, which is 2390.58% up from last year.
  • According to the latest figures from Q3 2020, AC Immune's Total Debt is $336773.3, which was down 4741.49% from $333137.6 recorded in Q2 2020.
  • AC Immune's Total Debt's 5-year high stood at $658770.1 during Q4 2019, with a 5-year trough of $255.31 in Q2 2019.
  • For the 4-year period, AC Immune's Total Debt averaged around $358156.9, with its median value being $334966.3 (2020).
  • Over the last 5 years, AC Immune's Total Debt had its largest YoY gain of 13038316.44% in 2020, and its largest YoY loss of 4741.49% in 2020.
  • Quarter analysis of 4 years shows AC Immune's Total Debt stood at $500708.2 in 2017, then increased by 3.95% to $520504.4 in 2018, then rose by 26.56% to $658770.1 in 2019, then plummeted by 48.88% to $336773.3 in 2020.
  • Its Total Debt stands at $336773.3 for Q3 2020, versus $333137.6 for Q2 2020 and $334966.3 for Q1 2020.